Skip to main content

Publisher: Wiley-Blackwell

Volume 11, Number 5, May 2010

Free Content Hospitalization risk following initiation of highly active antiretroviral therapy
pp. 289-298(10)
Authors: Berry, SA; Manabe, YC; Moore, RD; Gebo, KA

Favourites:
ADD

Free Content Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme
pp. 299-307(9)
Authors: Moore, DM; Zhang, W; Yip, B; Genebat, M; Lima, VD; Montaner, JSG; Hogg, RS

Favourites:
ADD

Free Content Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France
pp. 308-317(10)
Authors: Déti, EK; Thiébaut, R; Bonnet, F; Lawson-Ayayi, S; Dupon, M; Neau, D; Pellegrin, JL; Malvy, D; Tchamgoué, S; Dabis, F; Morlat, P

Favourites:
ADD

Free Content Development and initial validation of a brief screener for focused HIV prevention efforts
pp. 318-325(8)
Authors: Bennett, M; Strachan, E; Uldall, K

Favourites:
ADD

Free Content Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection
pp. 326-333(8)
Authors: Fabbiani, M; Di Giambenedetto, S; Ragazzoni, E; Colafigli, M; Prosperi, M; Cauda, R; Navarra, P; De Luca, A

Favourites:
ADD
Favourites:
ADD

Free Content Introduction of pharmacogenetic screening for the human leucocyte antigen (HLA) B*5701 variant in Polish HIV-infected patients
pp. 345-348(4)
Authors: Parczewski, M; Leszczyszyn-Pynka, M; Wnuk, A; Urbañska, A; Fuksiñska, K; Bander, D; Boroñ-Kaczmarska, A

Favourites:
ADD

Free Content Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2
pp. 349-352(4)
Authors: Ghezzi, S; Pacciarini, F; Nozza, S; Racca, S; Mariani, SA; Vicenzi, E; Lazzarin, A; Veglia, F; Tambussi, G; Poli, G

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more